Elan Drug Technologies

Navigation

• Home
• Careers
• Sitemap

Search:   Search

Strategy

Elan Drug Technologies develops and manufactures innovative pharmaceutical products that deliver clinically meaningful benefits to patients, using its extensive experience and proprietary drug technologies in partnership with pharmaceutical companies.

 

Our vision is to be the world’s leading drug delivery company and partner of choice for the pharmaceutical industry.


Throughout our 40 year history, we have invested in the development of innovative technologies, particularly in Oral Controlled Release platform technologies and technologies for poorly water soluble compounds, our NanoCrystal® technology. We are focused on profitably growing as a specialty drug delivery business, underpinned by our product development capabilities and drug delivery technologies.

In the near to medium term we will drive growth through our existing approved licensed products and pipeline of 14 products in clinical development. In addition we seek to generate new pipeline opportunities by entering into further licensing arrangements with pharmaceutical companies as well as identifying and developing proprietary products as we evolve our specialty pharmaceutical business model. As a leading provider of drug delivery technologies, we will continue to invest in the development and application of novel drug delivery technologies.


Our strategy, based on our comprehensive product development and proprietary technology platforms, involves two complementary elements:

• Working with pharmaceutical companies to develop products through the application of our technologies to their pipeline and marketed products; and
• Selectively developing product candidates based on our proprietary technologies (Proprietary Product Candidates or PPCs) where we originate the product concept and ultimately develop the product to a later stage of development prior to out-licensing or making a decision to continue internal development.

Our drug delivery technologies are key to our future business. We have more than 1,900 patent and patent applications filed world-wide directed to our technology and product areas.